State Street’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $333M | Sell |
3,232,532
-438,150
| -12% | -$28.5M | 0.01% | 758 |
|
|
2026
Q1 | $174M | Buy |
3,670,682
+42,864
| +1% | +$1.92M | 0.01% | 1019 |
|
|
2025
Q4 | $115M | Buy |
3,627,818
+538,755
| +17% | +$16.8M | ﹤0.01% | 1275 |
|
|
2025
Q3 | $86.9M | Buy |
3,089,063
+588,066
| +24% | +$17.8M | ﹤0.01% | 1414 |
|
|
2025
Q2 | $92M | Sell |
2,500,997
-192,677
| -7% | -$6.66M | ﹤0.01% | 1349 |
|
|
2025
Q1 | $106M | Buy |
2,693,674
+149,677
| +6% | +$6.74M | ﹤0.01% | 1237 |
|
|
2024
Q4 | $118M | Sell |
2,543,997
-623,356
| -20% | -$28.2M | ﹤0.01% | 1243 |
|
|
2024
Q3 | $143M | Buy |
3,167,353
+526,028
| +20% | +$25M | 0.01% | 1114 |
|
|
2024
Q2 | $130M | Sell |
2,641,325
-798,006
| -23% | -$32.5M | 0.01% | 1103 |
|
|
2024
Q1 | $118M | Buy |
3,439,331
+77,116
| +2% | +$2.78M | 0.01% | 1204 |
|
|
2023
Q4 | $124M | Sell |
3,362,215
-637,766
| -16% | -$14.7M | 0.01% | 1159 |
|
|
2023
Q3 | $81M | Sell |
3,999,981
-847,595
| -17% | -$18.6M | ﹤0.01% | 1318 |
|
|
2023
Q2 | $99.2M | Sell |
4,847,576
-428,265
| -8% | -$6.42M | 0.01% | 1222 |
|
|
2023
Q1 | $79.6M | Buy |
5,275,841
+849,592
| +19% | +$18.8M | ﹤0.01% | 1345 |
|
|
2022
Q4 | $105M | Buy |
4,426,249
+1,562,887
| +55% | +$45.3M | 0.01% | 1129 |
|
|
2022
Q3 | $101M | Sell |
2,863,362
-952,826
| -25% | -$40.5M | 0.01% | 1104 |
|
|
2022
Q2 | $133M | Buy |
3,816,188
+1,335,779
| +54% | +$47.3M | 0.01% | 977 |
|
|
2022
Q1 | $122M | Buy |
2,480,409
+879,566
| +55% | +$48.7M | 0.01% | 1154 |
|
|
2021
Q4 | $124M | Buy |
1,600,843
+231,038
| +17% | +$23.7M | 0.01% | 1130 |
|
|
2021
Q3 | $147M | Buy |
1,369,805
+85,192
| +7% | +$9.75M | 0.01% | 1008 |
|
|
2021
Q2 | $171M | Buy |
1,284,613
+76,323
| +6% | +$8.87M | 0.01% | 932 |
|
|
2021
Q1 | $150M | Buy |
1,208,290
+106,707
| +10% | +$16.2M | 0.01% | 943 |
|
|
2020
Q4 | $156M | Sell |
1,101,583
-334,923
| -23% | -$37.2M | 0.01% | 860 |
|
|
2020
Q3 | $109M | Sell |
1,436,506
-167,025
| -10% | -$10.4M | 0.01% | 918 |
|
|
2020
Q2 | $72.6M | Buy |
1,603,531
+644,391
| +67% | +$23.1M | 0.01% | 1181 |
|
|
2020
Q1 | $29.3M | Buy |
959,140
+70,093
| +8% | +$1.88M | ﹤0.01% | 1588 |
|
|
2019
Q4 | $18.7M | Buy |
889,047
+16,400
| +2% | +$384K | ﹤0.01% | 2181 |
|
|
2019
Q3 | $20.8M | Buy |
872,647
+229,604
| +36% | +$6.67M | ﹤0.01% | 2037 |
|
|
2019
Q2 | $18.7M | Buy |
643,043
+576,661
| +869% | +$15.3M | ﹤0.01% | 2152 |
|
|
2019
Q1 | $1.54M | Buy |
66,382
+19,382
| +41% | +$438K | ﹤0.01% | 3244 |
|
|
2018
Q4 | $1.08M | Buy |
+47,000
| New | +$1.04M | ﹤0.01% | 3307 |
|
Other funds holding TWST
AIM
EIG
FCM
State Street's TWST Position: Q2 2026 in Review
State Street reduced its Twist Bioscience (TWST) stake by 12% in Q2 2026, selling an estimated $28.5M and leaving 3,232,532 shares worth $333M. The position accounts for 0.01% of the portfolio, ranked #758.
State Street first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- State Street held 3,232,532 shares of Twist Bioscience worth $333M as of Q2 2026.
- State Street sold 438,150 Twist Bioscience shares in Q2 2026, an estimated $28.5M.
- Twist Bioscience made up 0.01% of State Street's portfolio in Q2 2026, its #758 holding.
- State Street first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
- 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.